학술논문
Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial
Document Type
Article
Author
Mackey, John R; Martin, Miguel; Pienkowski, Tadeusz; Rolski, Janusz; Guastalla, Jean-Paul; Sami, Amer; Glaspy, John; Juhos, Eva; Wardley, Andrew; Fornander, Tommy; Hainsworth, John; Coleman, Robert; Modiano, Manuel R; Vinholes, Jeferson; Pinter, Tamas; Rodríguez-Lescure, Álvaro; Colwell, Bruce; Whitlock, Pierre; Provencher, Louise; Laing, Kara; Walde, David; Price, Chris; Hugh, Judith C; Childs, Barrett H; Bassi, Kimberly; Lindsay, Mary-Ann; Wilson, Véronique; Rupin, Matthieu; Houé, Vincent; Vogel, Charles
Source
In Lancet Oncology January 2013 14(1):72-80
Subject
Language
ISSN
1470-2045